TUSTIN, Calif.--(BUSINESS WIRE)--May 20, 2023--

The Finals is back for an Open Beta free for everyone, including console players who'd previously been excluded.

TCL is bringing its Nxtpaper 2.0 technology to a couple of new smartphones. This colorized

With the “Transformers” franchise clearly at a crossroads, its protectors have turned to their deep bench

Do these things when your Cims can't pay rent!

Elon Musk has denied reports that his brain implant startup Neuralink killed monkeys during research experiments, claiming instead that tests were only done on “terminal” primates. Neuralink admitted to euthanizing eight animals during trials of its brain-computer interface technology last year, however denied accusations from the Physicians Committee for Responsible Medicine (PCRM) that it subjected monkeys to “extreme suffering”. The animal rights group accused Neuralink of “inadequate animal care” at the company’s lab at the University of California’s Davis Primate Centre, alleging that nine violations of the Animal Welfare Act were committed. Neuralink defended its animal testing record in a blog post last year, claiming that it is “absolutely committed to working with animals in the most humane and ethical way possible”. The firm also noted that “all novel medical devices and treatments” must be tested on animals before they can be trialled on humans. “The use of every animal was extensively planned and considered to balance scientific discovery with the ethical use of animals,” the blog post stated. Neuralink CEO Elon Musk has now added more details about the startup’s animal testing practices, after the issue was brought up by one of his followers on X, formerly known as Twitter. “No monkey has died as a result of a Neuralink implant,” Mr Elon Musk posted to X. “First our early implants, to minimise risk to healthy monkeys, we chose terminal monkeys (close to death already).” Mr Musk founded Neuralink in 2016 with the ultimate aim of merging artificial intelligence with the human brain. An implanted chip could improve hearing and vision, while also delivering “enhanced abilities” like greater reasoning and anxiety relief, according to the tech billionaire. Early applications of the technology will be for treating brain disorders and neurological conditions, though the company is yet to set a date for when its chips will be ready to use. In May, Neuralink revealed that it had received approval from the US Food and Drug Administration (FDA) to begin testing its technology on humans. Neuralink said that FDA approval “represents an important first step that will one day allow our technology to help many people”. Read More 10 ways AI will change the world – from curing cancer to wiping out humanity SpaceX launch of Starship rocket on hold amid ‘mishap investigation’ Famed tech journalist deletes X account with epic rant at Elon Musk First photo emerges of Elon Musk and his baby twins with Neuralink director

Alphabet-owned Google is planning to make its suite of artificial intelligence-powered tools available to corporate Gmail accounts at

Well, that was certainly a lot of Apple news to take in. This year's WWDC

Ötzi the Iceman may have gone bald in middle age—but hey, at least he had tattoos.

Tate's arrival on Rumble resulted in a notable increase in number of users on the platform on the week he joined

Big tech appears to be continuing its strong growth turnaround from last year, as it kicks off earnings report season for the quarter ended in September.

AUSTIN, Texas & BETHESDA, Maryland--(BUSINESS WIRE)--May 17, 2023--